Review: AI for identifying tumor-reactive CD8⁺ T cells

A review argues AI is shifting tumor-reactive CD8⁺ T cell identification from heuristic screening to predictive science via single-cell transcriptomics, clonal tracking and TCR-pMHC structural modeling. Yet algorithms still conflate terminal exhaustion with tumor reactivity and suffer dataset survivorship bias.